These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3800227)

  • 1. [Depigmenting chemical agents].
    Ortonne JP
    Ann Dermatol Venereol; 1986; 113(8):733-6. PubMed ID: 3800227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic depigmentation agents].
    Grosshans E; Chartier C
    Schweiz Rundsch Med Prax; 1987 Sep; 76(39):1077-81. PubMed ID: 3671942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind clinical study of the treatment of melasma with azelaic acid versus hydroquinone].
    Piquero Martín J; Rothe de Arocha J; Beniamini Loker D
    Med Cutan Ibero Lat Am; 1988; 16(6):511-4. PubMed ID: 3073279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of hydroquinone in the treatment of cutaneous hyperpigmentation in hairless descendants of Mexican hairless dogs (Xoloitzcuintli).
    Kimura T; Doi K
    Lab Anim Sci; 1998 Oct; 48(5):469-75. PubMed ID: 10090060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents.
    Saxena S; Andersen RM; Maibach HI
    J Dermatolog Treat; 2015 Oct; 26(5):440-50. PubMed ID: 25669434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
    Dadzie OE; Petit A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical agents used in association with cosmetic surgery.
    Draelos ZD
    Semin Cutan Med Surg; 1999 Jun; 18(2):112-8. PubMed ID: 10385279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
    Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
    Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depigmenting potency of hydroquinone fatty acid esters on the skin.
    Hashimoto A; Hasegawa K; Asai T; Masamoto Y; Ichihashi M; Mishima Y
    J Dermatol; 1988 Feb; 15(1):37-43. PubMed ID: 3292617
    [No Abstract]   [Full Text] [Related]  

  • 12. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin lightening agents - Use or abuse? - A retrospective analysis of the topical preparations used by melasma patients of darker skin types.
    Kandhari R; Khunger N
    Indian J Dermatol Venereol Leprol; 2013; 79(5):701-2. PubMed ID: 23974587
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.
    Fitzpatrick TB; Arndt KA; el-Mofty AM; Pathak MA
    Arch Dermatol; 1966 May; 93(5):589-600. PubMed ID: 5940924
    [No Abstract]   [Full Text] [Related]  

  • 15. Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
    Becker JC; Schrama D
    J Invest Dermatol; 2011 Jun; 131(6):1185-7. PubMed ID: 21566576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hydroquinone as a bleaching cream.
    Yi K; Hart LL
    Ann Pharmacother; 1993 May; 27(5):592-3. PubMed ID: 8347912
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of topical flutamide in the treatment of melasma.
    Bagherani N
    Dermatol Ther; 2016 Sep; 29(5):297. PubMed ID: 27712039
    [No Abstract]   [Full Text] [Related]  

  • 19. Azelaic acid esters do not depigment pigmented guinea pig skin.
    Wilkerson MG; Wilkin JK
    Arch Dermatol; 1990 Feb; 126(2):252-3. PubMed ID: 2301969
    [No Abstract]   [Full Text] [Related]  

  • 20. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
    Mosher DB; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.